UK markets close in 7 hours 12 minutes

Recordati Industria Chimica e Farmaceutica S.p.A. (REC.MI)

Milan - Milan Delayed price. Currency in EUR
Add to watchlist
49.40-0.58 (-1.16%)
As of 10:03AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 10.31B
Enterprise value 11.90B
Trailing P/E 26.86
Forward P/E 16.86
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.02
Price/book (mrq)6.12
Enterprise value/revenue 5.72
Enterprise value/EBITDA 16.80

Trading information

Stock price history

Beta (5Y monthly) 0.36
52-week change 320.99%
S&P500 52-week change 322.64%
52-week high 353.40
52-week low 340.05
50-day moving average 351.18
200-day moving average 347.55

Share statistics

Avg vol (3-month) 3211.46k
Avg vol (10-day) 3270.02k
Shares outstanding 5206.37M
Implied shares outstanding 6217.18M
Float 897.53M
% held by insiders 151.82%
% held by institutions 129.30%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.26
Forward annual dividend yield 42.52%
Trailing annual dividend rate 31.20
Trailing annual dividend yield 32.40%
5-year average dividend yield 42.42
Payout ratio 462.87%
Dividend date 3N/A
Ex-dividend date 420 May 2024
Last split factor 24:1
Last split date 318 Apr 2005

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 18.69%
Operating margin (ttm)34.73%

Management effectiveness

Return on assets (ttm)9.54%
Return on equity (ttm)24.08%

Income statement

Revenue (ttm)2.08B
Revenue per share (ttm)10.13
Quarterly revenue growth (yoy)10.60%
Gross profit (ttm)N/A
EBITDA 757.12M
Net income avi to common (ttm)389.21M
Diluted EPS (ttm)1.86
Quarterly earnings growth (yoy)19.50%

Balance sheet

Total cash (mrq)221.81M
Total cash per share (mrq)1.08
Total debt (mrq)1.83B
Total debt/equity (mrq)108.45%
Current ratio (mrq)1.20
Book value per share (mrq)8.19

Cash flow statement

Operating cash flow (ttm)485.32M
Levered free cash flow (ttm)32.58M